ERIN HAGEMEISTER: Open Payments
NPI 1811065766 · HARVEY, ND. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$125 in 7 payments from 6 companies in 2025. Trend: 2023 $204 · 2024 $249 · 2025 $125
Food & beverage: $125
| Company | Payments | Amount |
|---|---|---|
| Alkermes, Inc. | 2 | $35 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $30 |
| ABBVIE INC. | 1 | $15 |
| Collegium Pharmaceutical, Inc. | 1 | $15 |
| Neurocrine BioSciences, Inc. | 1 | $15 |
| Otsuka America Pharmaceutical, Inc. | 1 | $14 |
Products named: LYBALVI, TRINTELLIX, VRAYLAR, Jornay PM, INGREZZA, REXULTI.
Industry payments across ND — which companies pay providers there.
